Literature DB >> 8352343

Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.

B V Siegel1, M S Buchsbaum, W E Bunney, L A Gottschalk, R J Haier, J B Lohr, S Lottenberg, A Najafi, K H Nuechterlein, S G Potkin.   

Abstract

OBJECTIVE: The cortical-striatal-thalamic circuit modulates cognitive processing and thus may be involved in the cognitive dysfunction in schizophrenia. The imaging of metabolic rate in the structures making up this circuit could reveal the correlates of schizophrenia and its main symptoms.
METHOD: Seventy male schizophrenic patients underwent [18F]-fluorodeoxyglucose positron emission tomography after a period of at least 4 weeks during which they had not received neuroleptic medication and were compared to 30 age-matched male normal comparison subjects.
RESULTS: Analyses revealed decreased metabolism in medial frontal cortex, cingulate gyrus, medial temporal lobe, corpus callosum, and ventral caudate and increased metabolism in the left lateral temporal and occipital cortices in the schizophrenic cohort. Consistent with previous studies, the schizophrenic group had lower hypofrontality scores (ratios of lateral frontal to occipital metabolism) than did comparison subjects. The lateral frontal cortical metabolism of schizophrenic patients did not differ from that of comparison subjects, while occipital cortical metabolism was high, suggesting that lateral hypofrontality is due to abnormalities in occipital rather than lateral frontal activity. Hypofrontality was more prominent in medial than lateral frontal cortex. Brief Psychiatric Rating Scale (BPRS) scores, obtained for each schizophrenic patient on the scan day, were correlated with regional brain glucose metabolic rate. Medial frontal cortical and thalamic activity correlated negatively with total BPRS score and with positive and negative symptom scores. Lateral frontal cortical metabolism and hypofrontality scores did not significantly correlate with negative symptoms. Analyses of variance demonstrated a reduced right greater than left asymmetry in the schizophrenic patients for the lateral cortex as a whole, with simple interactions showing this effect specifically in temporal and frontal cortical regions.
CONCLUSIONS: Low metabolic rates were confirmed in medial frontal cortical regions as well as in the basal ganglia, consistent with the importance of the cortical-striatal-thalamic pathways in schizophrenia. Loss of normal lateralization patterns was also observed on an exploratory basis. Correlations with negative symptoms and group differences were more prominent in medial than lateral frontal cortex, suggesting that medial regions may be more important in schizophrenic pathology.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352343     DOI: 10.1176/ajp.150.9.1325

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  28 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 2.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

3.  Comparison of Classical and Clozapine Treatment on Schizophrenia Using Positive and Negative Syndrome Scale of Schizophrenia (PANSS) and SPECT Imaging.

Authors:  Mohammad Sharafi
Journal:  Int J Med Sci       Date:  2005-05-10       Impact factor: 3.738

4.  Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study.

Authors:  J D Ragland; R C Gur; J Raz; L Schroeder; C G Kohler; R J Smith; A Alavi; R E Gur
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

5.  Reduced frontal asymmetry of delta waves during all-night sleep in schizophrenia.

Authors:  Masanori Sekimoto; Masaaki Kato; Tsuyoshi Watanabe; Naofumi Kajimura; Kiyohisa Takahashi
Journal:  Schizophr Bull       Date:  2006-12-16       Impact factor: 9.306

6.  Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives.

Authors:  S Lui; L Yao; Y Xiao; S K Keedy; J L Reilly; R S Keefe; C A Tamminga; M S Keshavan; G D Pearlson; Q Gong; J A Sweeney
Journal:  Psychol Med       Date:  2014-05-20       Impact factor: 7.723

7.  Molecular components of striatal plasticity: the various routes of cyclic AMP pathways.

Authors:  A Rajadhyaksha; J Leveque; W Macías; A Barczak; C Konradi
Journal:  Dev Neurosci       Date:  1998       Impact factor: 2.984

8.  Creatine abnormalities in schizophrenia and bipolar disorder.

Authors:  Dost Ongür; Andrew P Prescot; J Eric Jensen; Bruce M Cohen; Perry F Renshaw
Journal:  Psychiatry Res       Date:  2009-02-23       Impact factor: 3.222

9.  Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism.

Authors:  James Edward Bryant; Michael Frölich; Steve Tran; Meredith Amanda Reid; Adrienne Carol Lahti; Nina Vanessa Kraguljac
Journal:  J Psychiatr Res       Date:  2019-07-27       Impact factor: 4.791

10.  Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.